Compositions and methods for controlling nematodes

US10827753B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10827753-B2
Application numberUS-201916507535-A
CountryUS
Kind codeB2
Filing dateJul 10, 2019
Priority dateAug 13, 2007
Publication dateNov 10, 2020
Grant dateNov 10, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions and methods for controlling nematodes are described herein, e.g., nematodes that infest plants or animals. The compounds include oxazoles, oxadiazoles and thiadiazoles.

First claim

Opening claim text (preview).

What is claimed is: 1. A nematicidal composition comprising: an effective amount of a compound of Formula IV, Formula V, or a salt thereof wherein, A is phenyl, pyrazyl, oxazolyl or isoxazolyl, each of which can be optionally independently substituted with one or more substituents selected from the group consisting of halogen, CF 3 , CH 3 , OCF 3 , OCH 3 , CN, and C(H)O; and C is thienyl, furanyl, oxazolyl or isoxazolyl, each of which can be optionally independently substituted with one or more substituents selected from the group consisting of fluorine, chlorine, CH 3 , and OCF 3 ; and one or more of an insecticide, a fungicide, a herbicide, or another pesticide selected from the group consisting of an avermectin, milbemycin, imidacloprid, aldicarb, oxamyl, fenamiphos, fosthiazate, metam sodium, etridiazole, penta-chloro-nitrobenzene (PCNB), flutolanil, metalaxyl, mefonoxam, fosetyl-al, silthiofam, fludioxonil, myclobutanil, azoxystrobin, chlorothalonil, propiconazole, tebuconazole, pyraclostrobin, trifloxysulfuron, glyphosate, and halosulfuron. 2. The composition of claim 1 wherein A is phenyl. 3. The composition of claim 1 wherein A is pyrazyl. 4. The composition of claim 1 wherein A is oxazolyl. 5. The composition of claim 1 wherein A is isoxazolyl. 6. The composition of claim 1 wherein C is thienyl. 7. The composition of claim 1 wherein C is furanyl. 8. The composition of claim 1 wherein C is oxazolyl. 9. The composition of claim 1 wherein C is isoxazolyl. 10. The composition of claim 1 comprising a compound of Formula IVa or a salt thereof, wherein R 1 and R 5 are independently selected from hydrogen, CH 3 , F, Cl, Br, CF 3 and OCF 3 ; R 2 and R 4 are independently selected from hydrogen, F, Cl, Br, and CF 3 ; R 3 is selected from hydrogen, CH 3 , CF 3 , F, Cl, Br, OCF 3 , OCH 3 , CN, and C(H)O; R 7 and R 8 are independently selected from hydrogen and fluorine; R 9 is selected from hydrogen, F, Cl, CH 3 , and OCF 3 ; and E is O or S. 11. The composition of claim 1 comprising a compound of Formula IVb or a salt thereof, wherein R 1 and R 5 are independently selected from hydrogen, CH 3 , F, Cl, Br, CF 3 and OCF 3 ; R 2 and R 4 are independently selected from hydrogen, F, Cl, Br, and CF 3 ; R 3 is selected from hydrogen, CH 3 , CF 3 , F, Cl, Br, OCF 3 , OCH 3 , CN, and C(H)O; R 8 is selected from hydrogen and fluorine; R 6 and R 9 are independently selected from hydrogen, F, Cl, CH 3 , and OCF 3 ; and E is O or S. 12. The composition of claim 1 comprising a compound of Formula Va or a salt thereof, wherein, R 1 and R 5 are independently selected from hydrogen, CH 3 , F, Cl, Br, CF 3 and OCF 3 ; R 2 and R 4 are independently selected from hydrogen, F, Cl, Br, and CF 3 ; R 3 is selected from hydrogen, CH 3 , CF 3 , F, Cl, Br, OCF 3 , OCH 3 , CN, and C(H)O; R 7 and R 8 are independently selected from hydrogen and fluorine; R 9 is selected from hydrogen, F, Cl, CH 3 , and OCF 3 ; and E is O or S. 13. The composition of claim 1 comprising a compound of Formula Vb or a salt thereof, wherein R 1 and R 5 are independently selected from hydrogen, CH 3 , F, Cl, Br, CF 3 and OCF 3 ; R 2 and R 4 are independently selected from hydrogen, F, Cl, Br, and CF 3 ; R 3 is selected from hydrogen, CH 3 , CF 3 , F, Cl, Br, OCF 3 , OCH 3 , CN, and C(H)O; R 8 is selected from hydrogen and fluorine; R 6 and R 9 are independently selected from hydrogen, F, Cl, CH 3 , and OCF 3 ; and E is O or S. 14. The composition of claim 10 wherein E is O. 15. The composition of claim 10 wherein E is S. 16. The composition of claim 1 comprising a compound selected from the group consisting of: 3-phenyl-5-(thiophen-2-yl)-1,2,4-oxadiazole, 5-(furan-2-yl)-3-phenyl-1,2,4-oxadiazole, 3-(4-fluorophenyl)-5-(thiophen-2-yl)-1,2,4-oxadiazole, 3-(4-fluorophenyl)-5-(furan-2-yl)-1,2,4-oxadiazole, 3-(4-chlorophenyl)-5-(thiophen-2-yl)-1,2,4-oxadiazole, 3-(4-chlorophenyl)-5-(furan-2-yl)-1,2,4-oxadiazole, 3-(4-bromophenyl)-5-(thiophen-2-yl)-1,2,4-oxadiazole, 3-(4-bromophenyl)-5-(furan-2-yl)-1,2,4-oxadiazole, 3-(4-chloro-2-methylphenyl)-5-(furan-2-yl)-1,2,4-oxadiazole, 3-(2,4-dichlorophenyl)-5-(furan-2-yl)-1,2,4-oxadiazole, 3-(4-chlorophenyl)-5-(thiophen-3-yl)-1,2,4-oxadiazole, 3-(4-chlorophenyl)-5-(furan-3-yl)-1,2,4-oxadiazole, 3-(4-fluorophenyl)-5-(thiophen-3-yl)-1,2,4-oxadiazole, and 3-(4-fluorophenyl)-5-(furan-3-yl)-1,2,4-oxadiazole. 17. The composition of claim 16 comprising 3-phenyl-5-(thiophen-2-yl)-1,2,4-oxadiazole. 18. The composition of claim 1 further comprising water. 19. The composition of claim 1 in the form of a concentrate. 20. The composition of claim 1 further comprising a solvent in which the compound of Formula IV, Formula V, or a salt thereof is dissolved. 21. The composition of claim 20 further comprising a co-solvent. 22. The composition of claim 21 wherein the co-solvent is selected from the group consisting of ethyl lactate, methyl soyate, isopropanol, acetone, 1,2-propanediol, n-alkylpyrrolidone, petroleum-based oil and mineral oil. 23. The composition of claim 1 further comprising an aqueous surfactant. 24. The composition of claim 1 further comprising a permeation enhancer. 25. The composition of claim 16 comprising 5-(furan-2-yl)-3-phenyl-1,2,4-oxadiazole.

Assignees

Inventors

Classifications

  • A01N43/76Primary

    1,3-Oxazoles; Hydrogenated 1,3-oxazoles · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

  • containing a —O—CO—N< group, or a thio analogue thereof, neither directly attached to a ring nor the nitrogen atom being a member of a heterocyclic ring · CPC title

  • containing three or more hetero rings · CPC title

  • C07D417/04Primary

    directly linked by a ring-member-to-ring-member bond · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10827753B2 cover?
Compositions and methods for controlling nematodes are described herein, e.g., nematodes that infest plants or animals. The compounds include oxazoles, oxadiazoles and thiadiazoles.
Who is the assignee on this patent?
Monsanto Technology Llc
What technology area does this patent fall under?
Primary CPC classification A01N43/76. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).